Gait Adaptation and Biofeedback for Cerebral Palsy
University of Washington · with National Institute of Neurological Disorders and Stroke (NINDS), Gillette Children's Specialty Healthcare · NCT05899153
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 7–18 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 36
- US sites recruiting
- 1
- Study start
- November 28, 2023
- Record last updated
- June 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This research aims to evaluate walking function in children with cerebral palsy (CP). The researchers want to understand how children with CP adapt and learn new ways of moving. They have previously found that measuring how a person controls their muscles is important for assessing walking ability and response to interventions. In these studies, they will adjust the treadmill belt speeds and/or provide real-time feedback to evaluate how a child can alter their movement. The feedback will include a wearable exoskeleton that provides resistance to the ankle and audio and visual cues based on sensors that record muscle activity. This research will investigate three goals: first, to measure how children with CP adapt their walking; second, to see if either repeated training or orthopedic surgery can improve adaptation rates; and third, to determine if individual differences in adaptation relate to improvements in walking function after treatment. This research will help develop better treatments to enhance walking capacity and performance for children with CP.
Being studied: Biomotum Spark: Robotic ankle resistance; Audiovisual Biofeedback; Multilevel Orthopedic Surgery
Conditions: Cerebral Palsy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Diagnosis of bilateral cerebral palsy that impacts both legs
- Gross Motor Functional Classification System Level II
- No surgery or lower-extremity injuries 12 months prior to enrollment
- No botulinum toxin injections in prior 3 months
- No prior selective dorsal rhizotomy surgery
- No history of seizures or cardiac conditions that would preclude walking on a treadmill for 20 minutes
- No current pain that hinders walking
Recruiting US locations
Gillette Children's
Saint Paul, MN 55101
Site contact: Alyssa Spomer, PhD · 651-229-3904 · AlyssaMSpomer@gillettechildrens.com
Study contacts (from the official record)
- Katherine M Steele, PhD · 206-685-2390 · kmsteele@uw.edu
- Alyssa Spomer, PhD · AlyssaMSpomer@gillettechildrens.com
Similar studies in Minnesota
All healthy volunteers studies in Minnesota →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
- Location
- Dilworth, MN + 2 other US sites
- Eligibility basics
- Ages 25–75
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- Saint Paul, MN + 3 other US sites
- Eligibility basics
- Ages 18–75